LIMN
Liminatus Pharma, Inc.Company with tickers: LIMN, LIMNW
CIK
1971387
CUSIP
53271X108
Shares Outstanding
44,877,633
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-07-10 | Lemons II Philip Wayne | Director | Other | 0 |
| 2025-07-10 | Baek Richard JaiHwan | Director | Other | 0 |
| 2025-04-30 | Iris Acquisition Holdings LLC | 10% Owner | Other | 6,900,000 |
| 2025-04-30 | KH Feelux Co., Ltd | 10% Owner | Other | 4,000,000 |
| 2025-04-30 | Valetudo Therapeutics LLC | 10% Owner | Other | 6,169,406 |
| 2025-04-30 | Lee Eun Sook | Director | Other | 0 |
| 2025-04-30 | Baek Ji Yeon | Director | Other | 0 |
| 2025-04-30 | Kim Chris | Director, Chief Executive Officer, 10% Owner | Other | 6,169,406 |
| 2025-04-30 | Choi Beom Kyu | Chief Technology Officer | Other | 0 |
| 2025-04-30 | Yoo Byong Chul | Chief Science Officer | Other | 0 |
| 2025-04-30 | Lee Sang-Jin | Head of Research & Development | Other | 0 |
| 2025-04-30 | Fernandez Nicholas | Director | Other | 0 |
| 2025-04-30 | Dam Scott | Chief Financial Officer | Other | 0 |